These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17418)

  • 1. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
    Sofia RD; Diamantis W; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs.
    Banerjee BN; Sofia RD; Ivins NJ; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):793-801. PubMed ID: 301393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.
    Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD
    Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429).
    Edelson J; Douglas JF; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):789-93. PubMed ID: 301392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological study of some 3-(isoxazol-5-yl)-quinazolin-4(3H)-ones.
    Plescia S; Daidone G; Raffa D; Bajardi ML; Caruso A; Cutuli V; Amico-Roxas M
    Farmaco; 1992 Apr; 47(4):465-75. PubMed ID: 1388594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats.
    Sofia RD; Diamantis W; Ludwig BJ
    J Pharm Sci; 1975 Aug; 64(8):1321-4. PubMed ID: 1151704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological studies on quinazoline-2, 4-dione derivaties, H-27 and H-88: (1) anti-inflammatory, analgesic and antipyretic activities].
    Fujimura H; Tsurumi K; Nozaki M; Hiramatsu Y; Tamura Y
    Nihon Yakurigaku Zasshi; 1974 Sep; 70(5):673-96. PubMed ID: 4532970
    [No Abstract]   [Full Text] [Related]  

  • 10. The disposition of 3-methyl-2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2451).
    Kucharczyk N; Ballard F; Yang J; Myers G; Sofia RD
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):180-94. PubMed ID: 114130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the pharmacology of butibufen, a non-steroidal anti-inflammatory agent.
    Aparicio L
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):130-41. PubMed ID: 901061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-inflammatory activity of 3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]benzoxazin-9-ones and related compounds.
    Reisner DB; Ludwig BJ; Stiefel FJ; Gister S; Meyer M; Powell LS; Sofia RD
    Arzneimittelforschung; 1977; 27(4):760-6. PubMed ID: 301390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):401-7. PubMed ID: 4153360
    [No Abstract]   [Full Text] [Related]  

  • 14. D-propoxyphene and dipyrone co-administration produces greater antinociception and fewer adverse effects than single treatments in rats.
    Silva-Moreno A; López-Muñoz FJ; Cruz SL
    Eur J Pharmacol; 2009 Apr; 607(1-3):84-90. PubMed ID: 19232342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of derivatives of isoxazolo[4,3-d]pyrimidine. III.
    Wagner E; Poreba K; Jakowicz I; Balicka D; Rutkowska M; Kedzierska-Goździk L; Szelag A
    Farmaco; 1995 Mar; 50(3):183-7. PubMed ID: 7755866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on non-steroidal anti-inflammatory and related biological activities of 5-(indan-1'-yl)tetrazoles and their intermediates.
    Ray SM; Roy A; Lahiri SC
    Indian J Physiol Pharmacol; 1990 Apr; 34(2):109-14. PubMed ID: 2253978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological screening of 1,3,4-thiadiazino[2,3-b]quinazoline derivatives.
    Santagati A; Modica M; Santagati M; Cutuli VM; Mangano NG; Caruso A
    Pharmazie; 2000 Oct; 55(10):737-40. PubMed ID: 11082833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological properties of 1,4-dihydro-1-ethyl-7-phenylpyrrol (1,2-a)-pyrimidine-4-one, a new antipyretic and analgesic drug.
    Evangelista S; Pirisino R; Perretti F; Fantozzi R; Brunelleschi S; Malmberg-Aiello P; Bartolini A
    Drugs Exp Clin Res; 1987; 13(8):501-8. PubMed ID: 2827981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.